In addition, other studies have indicated that CAFs regulate glutaminolysis in CRC and prostate cancer via distinct pathways, such as glutamine synthetase in CRC and Ras, which activates micropinocytosis, in prostate cancer [80, 81]. The gene discussed is GLUL; the disease is prostate carcinoma.